Children who use antipsychotic drugs were at greater risk of developing metabolic syndrome as treatment continues, a study presented at the Annual Congress of the European College of Neuropsychopharmacology indicated. Spanish researchers said about 22%, 24% and 33% of children were considered at risk for metabolic syndrome after three-, six- and 12-months of use of antipsychotic drugs respectively.

Related Summaries